Literature DB >> 8818128

When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.

B O'Brien1, A Gafni.   

Abstract

There is growing interest in the application of cost-benefit analysis (CBA) as a technique for the economic evaluation of health care programs. A distinguishing feature of CBA is that costs and benefits are expressed in the same units of value--typically money. A popular method for estimating money values for health care programs is the use of willingness-to-pay (or accept) survey techniques known as contingent valuation. This paper presents a conceptual framework to help in the interpretation or design of contingent valuation studies in health care. To be consistent with the theory upon which CBA is built, the authors consider what types of questions should be asked of what populations. They conclude that studies undertaking contingent valuation should distinguish between compensating variation and equivalent variation, and recognize that respondents can be gainers or losers in utility and therefore should be asked willingness-to-pay (or accept) questions as appropriate. Current critical-appraisal guidance in the health care literature for CBA is poor and unlikely to offer useful demarcation between good and bad CBA studies. More work is needed exploring whether recently issued guidelines for contingent valuation in environment damage assessment are applicable to health care studies.

Mesh:

Year:  1996        PMID: 8818128     DOI: 10.1177/0272989X9601600314

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  57 in total

Review 1.  Willingness to pay and the valuation of programmes for the prevention and control of influenza.

Authors:  S Birch; A Gafni; B O'Brien
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 2.  Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.

Authors:  E McIntosh; C Donaldson; M Ryan
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

3.  Willingness to pay. What's in a name?

Authors:  A Gafni
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 4.  Willingness to pay as a measure of health benefits.

Authors:  M V Bala; J A Mauskopf; L L Wood
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

5.  Willingness to pay as patient preference to bariatric surgery.

Authors:  Cristina Khawali; Marcos B Ferraz; Maria T Zanella; Sandra R G Ferreira
Journal:  Health Expect       Date:  2011-11-10       Impact factor: 3.377

6.  Unexpected yes- and no-answering behaviour in the discrete choice approach to elicit willingness to pay: a methodological comparison with payment cards.

Authors:  Thomas Hammerschmidt; Hans-Peter Zeitler; Reiner Leidl
Journal:  Int J Health Care Finance Econ       Date:  2003-09

7.  Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.

Authors:  Kathryn A Phillips; Tara Maddala; F Reed Johnson
Journal:  Health Serv Res       Date:  2002-12       Impact factor: 3.402

8.  The measurement of contingent valuation for health economics.

Authors:  Ahmed M Bayoumi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.

Authors:  Sinaa A Al Aqeel; Mohammed Al-Sultan
Journal:  Saudi Pharm J       Date:  2011-12-24       Impact factor: 4.330

10.  The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia.

Authors:  Paul J Karanicolas; Shona E Smith; Richard I Inculet; Richard A Malthaner; Richard P Reynolds; Ron Goeree; Amiram Gafni
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.